Language Processing and TMS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorMedical College of Wisconsin

About this trial

This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Diagnosed with left hemisphere stroke

Consent date >= 1 month after stroke onset

Right-handed

Fluent in English

Disqualifiers

Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing

Non-decisional per decisionality questionnaire or other clinical assessment

Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)

A chronic medical condition that is not treated or is unstable

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcranial Magnetic Stimulation

    Device

    Deymed DuoMag XT-100 rTMS

Treatment groups

135 Participants
are divided into 3 treatment groups
Group A: Active TMSExperimental treatment 1 intervention
Group B: Control TMSActive comparator 1 intervention
Group C: Sham TMSSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Reaction time on language task performance

Improvement on language task performance as measured by decrease in reaction time.

Time frame
Language tasks administered immediately before and/or after TMS administration (same day).
2

Accuracy on language task performance

Improvement on language task performance as measured by increase in accuracy.

Time frame
Language tasks administered immediately before and/or after TMS administration (same day).

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.